Literature DB >> 32683336

Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness.

Chandrika S Bhat1, Latika Gupta2, S Balasubramanian3, Surjit Singh4, Athimalaipet V Ramanan5.   

Abstract

The pandemic of COVID-19 initially appeared to cause only a mild illness in children. However, it is now apparent that a small percentage of children can develop a hyperinflammatory syndrome labeled as Pediatric inflammatory multisystem syndrome - temporally associated with SARS-CoV-2 (PIMS-TS). Features of this newly recognized condition may include persistent fever, evidence of inflammation, and single or multi-organ dysfunction in the absence of other known infections. Some of these children may share features of Kawasaki disease, toxic shock syndrome or cytokine storm syndrome. They can deteriorate rapidly and may need intensive care support as well. The PCR test is more often negative; although, most of the children have antibodies to SARS-CoV-2. Although the pathogenesis is not clearly known, immune-mediated injury has been implicated. We herein provide current information on this condition, in order to raise awareness amongst pediatricians.

Entities:  

Mesh:

Year:  2020        PMID: 32683336      PMCID: PMC7605487     

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   3.839


  23 in total

1.  Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

Authors:  Tohru Kobayashi; Tsutomu Saji; Tetsuya Otani; Kazuo Takeuchi; Tetsuya Nakamura; Hirokazu Arakawa; Taichi Kato; Toshiro Hara; Kenji Hamaoka; Shunichi Ogawa; Masaru Miura; Yuichi Nomura; Shigeto Fuse; Fukiko Ichida; Mitsuru Seki; Ryuji Fukazawa; Chitose Ogawa; Kenji Furuno; Hirohide Tokunaga; Shinichi Takatsuki; Shinya Hara; Akihiro Morikawa
Journal:  Lancet       Date:  2012-03-08       Impact factor: 79.321

Review 2.  Role of intravenous immunoglobulin in the treatment of Kawasaki disease.

Authors:  Mindy S Lo; Jane W Newburger
Journal:  Int J Rheum Dis       Date:  2017-12-05       Impact factor: 2.454

3.  Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes.

Authors:  L Shen; M W Fanger
Journal:  Cell Immunol       Date:  1981-03-15       Impact factor: 4.868

Review 4.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

5.  Novel Coronavirus Mimicking Kawasaki Disease in an Infant.

Authors:  Bhaswati C Acharyya; Saumyabrata Acharyya; Dhritabrata Das
Journal:  Indian Pediatr       Date:  2020-05-22       Impact factor: 1.411

6.  Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children.

Authors:  Lucinda Tullie; Kathryn Ford; May Bisharat; Tom Watson; Hemanshoo Thakkar; Dhanya Mullassery; Stefano Giuliani; Simon Blackburn; Kate Cross; Paolo De Coppi; Joe Curry
Journal:  Lancet Child Adolesc Health       Date:  2020-05-20

7.  COVID-19: a case for inhibiting IL-17?

Authors:  Omar Pacha; Mary Alice Sallman; Scott E Evans
Journal:  Nat Rev Immunol       Date:  2020-06       Impact factor: 53.106

8.  The potential danger of suboptimal antibody responses in COVID-19.

Authors:  Akiko Iwasaki; Yexin Yang
Journal:  Nat Rev Immunol       Date:  2020-06       Impact factor: 53.106

9.  Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.

Authors:  Hai-Qiong Yu; Bao-Qing Sun; Zhang-Fu Fang; Jin-Cun Zhao; Xiao-Yu Liu; Yi-Min Li; Xi-Zhuo Sun; Hong-Feng Liang; Bei Zhong; Zhi-Feng Huang; Pei-Yan Zheng; Li-Feng Tian; Hui-Qi Qu; De-Chen Liu; Er-Yi Wang; Xiao-Jun Xiao; Shi-Yue Li; Feng Ye; Li Guan; Dong-Sheng Hu; Hakon Hakonarson; Zhi-Gang Liu; Nan-Shan Zhong
Journal:  Eur Respir J       Date:  2020-08-27       Impact factor: 16.671

10.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

Authors:  Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu; Jethro Herberg; Jane C Burns; Hermione Lyall; Michael Levin
Journal:  JAMA       Date:  2020-07-21       Impact factor: 157.335

View more
  10 in total

1.  Inclusion of Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID -19 in the Differential Diagnosis of Kawasaki Disease.

Authors:  Tushar Jagzape; Anil Kumar Goel
Journal:  Indian Pediatr       Date:  2021-02-15       Impact factor: 1.411

Review 2.  Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6.

Authors:  L Lacina; J Brábek; Š Fingerhutová; J Zeman; K Smetana
Journal:  Physiol Res       Date:  2021-04-30       Impact factor: 1.881

3.  Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome.

Authors:  Aman Gupta; Arpinder Gill
Journal:  J Trop Pediatr       Date:  2021-01-29       Impact factor: 1.165

4.  Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children.

Authors:  Fatih Haslak; Kenan Barut; Cansu Durak; Ayten Aliyeva; Mehmet Yildiz; Vafa Guliyeva; Sevki Erdem Varol; Sinem Oral Cebeci; Fatih Aygun; Yusuf Ziya Varli; Abdulrahman Ozel; Sertac Hanedan Onan; Ulkem Kocoglu; Meltem Erol; Fatih Karagozlu; Nujin Ulug; Reyhan Dedeoglu; Sezgin Sahin; Amra Adrovic; Funda Oztunc; Ozgur Kasapcopur
Journal:  Clin Rheumatol       Date:  2021-06-05       Impact factor: 2.980

5.  Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.

Authors:  Sheeja Sugunan; S Bindusha; S Geetha; H R Niyas; A Santhosh Kumar
Journal:  Indian Pediatr       Date:  2021-04-20       Impact factor: 3.839

6.  Multisystem inflammatory syndrome in Indian adolescents associated with SARS-CoV-2 infection: a case report.

Authors:  Rahul D Bhiwgade; M C Nischitha; Bhushan Shahare; Shobhna Bitey
Journal:  Egypt J Intern Med       Date:  2021-12-06

Review 7.  Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.

Authors:  Jayakanthan Kabeerdoss; Rakesh Kumar Pilania; Reena Karkhele; T Sathish Kumar; Debashish Danda; Surjit Singh
Journal:  Rheumatol Int       Date:  2020-11-21       Impact factor: 2.631

8.  Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.

Authors:  K Dhanalakshmi; Aishwarya Venkataraman; S Balasubramanian; Manoj Madhusudan; Sumanth Amperayani; Sulochana Putilibai; Kalaimaran Sadasivam; Bala Ramachandran; A V Ramanan
Journal:  Indian Pediatr       Date:  2020-08-06       Impact factor: 1.411

9.  Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India.

Authors:  Shreepal Jain; Supratim Sen; Srinivas Lakshmivenkateshiah; Prashant Bobhate; Sumitra Venkatesh; Soonu Udani; Laxmi Shobhavat; Parmanand Andankar; Tanuja Karande; Snehal Kulkarni
Journal:  Indian Pediatr       Date:  2020-08-11       Impact factor: 1.411

10.  Multisystem Inflammatory Syndrome in Children (MIS-C) - Recent Updates.

Authors:  Mangla Sood; Seema Sharma
Journal:  Indian Pediatr       Date:  2020-10-15       Impact factor: 3.839

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.